BIOMAT Database Logo BIOMAT Database Logo

Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia. 1989

S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Memorial Sloan Kettering Cancer Center, New York, NY.

UI MeSH Term Description Entries
D009926 Organ Preservation The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Organ Preservations,Preservation, Organ,Preservations, Organ
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow.
August 1992, Bone marrow transplantation,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia.
January 1991, Medical and pediatric oncology,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia.
December 1993, Bone marrow transplantation,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
December 1990, Bone marrow transplantation,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Autologous bone marrow transplantation with monoclonal antibody purged marrow for high risk acute lymphoblastic leukemia.
September 1989, Leukemia,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
March 1990, Blood,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
January 1992, Progress in clinical and biological research,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood.
January 1987, Haematology and blood transfusion,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
The role of VP-16 in autologous bone marrow transplantation for acute myeloblastic leukemia.
April 1996, The Journal of the Association of Physicians of India,
S C Gulati, and B Shank, and A Sarris, and E Berman, and T Gee, and I Cunningham, and N Flomenberg, and R J O'Reilly, and B Clarkson
GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia.
January 1992, Progress in clinical and biological research,
Copied contents to your clipboard!